531 related articles for article (PubMed ID: 10605035)
21. Characterization of the Fas ligand/Fas-dependent apoptosis of antiretroviral, class I MHC tetramer-defined, CD8+ CTL by in vivo retrovirus-infected cells.
Rich RF; Green WR
J Immunol; 2002 Mar; 168(6):2751-8. PubMed ID: 11884442
[TBL] [Abstract][Full Text] [Related]
22. Fas-mediated apoptosis causes elimination of virus-specific cytotoxic T cells in the virus-infected liver.
Liu ZX; Govindarajan S; Okamoto S; Dennert G
J Immunol; 2001 Mar; 166(5):3035-41. PubMed ID: 11207253
[TBL] [Abstract][Full Text] [Related]
23. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit T cell-mediated cytotoxicity by inhibiting Fas ligand expression.
Delgado M; Ganea D
J Immunol; 2000 Jul; 165(1):114-23. PubMed ID: 10861043
[TBL] [Abstract][Full Text] [Related]
24. The Fas/Fas ligand pathway is important for optimal tumor regression in a mouse model of CTL adoptive immunotherapy of experimental CMS4 lung metastases.
Caldwell SA; Ryan MH; McDuffie E; Abrams SI
J Immunol; 2003 Sep; 171(5):2402-12. PubMed ID: 12928387
[TBL] [Abstract][Full Text] [Related]
25. Xenospecific cytotoxic T lymphocytes: potent lysis in vitro and in vivo.
Smyth MJ; Kershaw MH; Trapani JA
Transplantation; 1997 Apr; 63(8):1171-8. PubMed ID: 9133481
[TBL] [Abstract][Full Text] [Related]
26. c-Myc controls the development of CD8alphaalpha TCRalphabeta intestinal intraepithelial lymphocytes from thymic precursors by regulating IL-15-dependent survival.
Jiang W; Ferrero I; Laurenti E; Trumpp A; MacDonald HR
Blood; 2010 Jun; 115(22):4431-8. PubMed ID: 20308599
[TBL] [Abstract][Full Text] [Related]
27. Development of insulitis without diabetes in transgenic mice lacking perforin-dependent cytotoxicity.
Kägi D; Odermatt B; Ohashi PS; Zinkernagel RM; Hengartner H
J Exp Med; 1996 May; 183(5):2143-52. PubMed ID: 8642324
[TBL] [Abstract][Full Text] [Related]
28. Tumor-specific CTL kill murine renal cancer cells using both perforin and Fas ligand-mediated lysis in vitro, but cause tumor regression in vivo in the absence of perforin.
Seki N; Brooks AD; Carter CR; Back TC; Parsoneault EM; Smyth MJ; Wiltrout RH; Sayers TJ
J Immunol; 2002 Apr; 168(7):3484-92. PubMed ID: 11907109
[TBL] [Abstract][Full Text] [Related]
29. Differential expression of Fas and Fas ligand in acute and chronic graft-versus-host disease: up-regulation of Fas and Fas ligand requires CD8+ T cell activation and IFN-gamma production.
Shustov A; Nguyen P; Finkelman F; Elkon KB; Via CS
J Immunol; 1998 Sep; 161(6):2848-55. PubMed ID: 9743345
[TBL] [Abstract][Full Text] [Related]
30. Treatment of melanoma with 5-fluorouracil or dacarbazine in vitro sensitizes cells to antigen-specific CTL lysis through perforin/granzyme- and Fas-mediated pathways.
Yang S; Haluska FG
J Immunol; 2004 Apr; 172(7):4599-608. PubMed ID: 15034078
[TBL] [Abstract][Full Text] [Related]
31. Perforin-independent CD8(+) T-cell-mediated cytotoxicity of alveolar epithelial cells is preferentially mediated by tumor necrosis factor-alpha: relative insensitivity to Fas ligand.
Liu AN; Mohammed AZ; Rice WR; Fiedeldey DT; Liebermann JS; Whitsett JA; Braciale TJ; Enelow RI
Am J Respir Cell Mol Biol; 1999 May; 20(5):849-58. PubMed ID: 10226053
[TBL] [Abstract][Full Text] [Related]
32. Differential role of Fas/Fas ligand interactions in cytolysis of primary and metastatic colon carcinoma cell lines by human antigen-specific CD8+ CTL.
Bergmann-Leitner ES; Abrams SI
J Immunol; 2000 May; 164(9):4941-54. PubMed ID: 10779805
[TBL] [Abstract][Full Text] [Related]
33. Most murine CD8+ intestinal intraepithelial lymphocytes are partially but not fully activated T cells.
Wang HC; Zhou Q; Dragoo J; Klein JR
J Immunol; 2002 Nov; 169(9):4717-22. PubMed ID: 12391179
[TBL] [Abstract][Full Text] [Related]
34. Perforin and Fas act together in the induction of apoptosis, and both are critical in the clearance of lymphocytic choriomeningitis virus infection.
Rode M; Balkow S; Sobek V; Brehm R; Martin P; Kersten A; Dumrese T; Stehle T; Müllbacher A; Wallich R; Simon MM
J Virol; 2004 Nov; 78(22):12395-405. PubMed ID: 15507626
[TBL] [Abstract][Full Text] [Related]
35. Fas ligand (CD95L) protects neurons against perforin-mediated T lymphocyte cytotoxicity.
Medana I; Li Z; Flügel A; Tschopp J; Wekerle H; Neumann H
J Immunol; 2001 Jul; 167(2):674-81. PubMed ID: 11441070
[TBL] [Abstract][Full Text] [Related]
36. Altered peptide ligands trigger perforin- rather than Fas-dependent cell lysis.
Bachmann MF; Ohteki T; Faienza KM; Zakarian A; Kägi D; Speiser DE; Ohashi PS
J Immunol; 1997 Nov; 159(9):4165-70. PubMed ID: 9379009
[TBL] [Abstract][Full Text] [Related]
37. Adaptive immunity and enhanced CD8+ T cell response to Listeria monocytogenes in the absence of perforin and IFN-gamma.
Badovinac VP; Harty JT
J Immunol; 2000 Jun; 164(12):6444-52. PubMed ID: 10843700
[TBL] [Abstract][Full Text] [Related]
38. Xenospecific cytotoxic T lymphocytes use perforin- and Fas-mediated lytic pathways.
Smyth MJ; Sutton VR; Kershaw MH; Trapani JA
Transplantation; 1996 Nov; 62(10):1529-32. PubMed ID: 8958289
[TBL] [Abstract][Full Text] [Related]
39. Multiple levels of activation of murine CD8(+) intraepithelial lymphocytes defined by OX40 (CD134) expression: effects on cell-mediated cytotoxicity, IFN-gamma, and IL-10 regulation.
Wang HC; Klein JR
J Immunol; 2001 Dec; 167(12):6717-23. PubMed ID: 11739485
[TBL] [Abstract][Full Text] [Related]
40. Comparison of Fas- versus perforin-mediated pathways of cytotoxicity in TCR- and Thy-1-activated murine T cells.
Kojima H; Toda M; Sitkovsky MV
Int Immunol; 2000 Mar; 12(3):365-74. PubMed ID: 10700471
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
